# Isolated nonparathyroid hormone-mediated hypercalcemia: a rare presentation of retroperitoneal sarcoidosis

**Authors:** Chao Xue, Ranjini Vengilote, Astrid Aviles-Melendez, Alshaima Yousef, Michael Quartuccio

PMC · DOI: 10.1210/jcemcr/luag028 · JCEM Case Reports · 2026-02-25

## TL;DR

A rare case of sarcoidosis presented as isolated hypercalcemia without lung involvement, requiring multiple biopsies for diagnosis.

## Contribution

This paper presents a rare clinical case of retroperitoneal sarcoidosis causing nonparathyroid hormone-mediated hypercalcemia with diagnostic challenges.

## Key findings

- The patient initially had normal 1,25(OH)₂D levels, complicating the diagnosis of sarcoidosis.
- Excisional biopsy of retroperitoneal lymph nodes confirmed nonnecrotizing granulomatous inflammation.
- Treatment with high-dose steroids normalized calcium levels.

## Abstract

Non-parathyroid hormone (PTH)-mediated hypercalcemia has diverse etiologies, including granulomatous disorders such as sarcoidosis, in which extrarenal 1-α-hydroxylase activity leads to excess production of 1,25-dihydroxyvitamin D (1,25(OH)₂D). We report a rare case of sarcoidosis presenting as isolated hypercalcemia without pulmonary involvement, complicated by initially normal 1,25(OH)₂D levels and a false-negative core biopsy. A 44-year-old man with hypertension and type 2 diabetes presented with malaise, polyuria, and polydipsia. Laboratory evaluation showed severe hypercalcemia with suppressed PTH. PTH-related peptide, 25-hydroxyvitamin D, TSH, and albumin were normal. Imaging revealed no osseous lesions or lymphadenopathy. He improved with intravenous fluids, calcitonin, and zoledronic acid. Three months later, he re-presented with recurrent hypercalcemia and elevated 24-hour urinary calcium excretion. Outpatient evaluation revealed elevated 1,25(OH)₂D and retroperitoneal lymphadenopathy. Core needle biopsy was nondiagnostic, but subsequent excisional biopsies of retroperitoneal lymph node confirmed nonnecrotizing granulomatous inflammation. He was diagnosed with sarcoidosis and started on high-dose steroids, later transitioning to mycophenolate. With that treatment, calcium levels normalized quickly. This case highlights the diagnostic complexities of non-PTH-mediated hypercalcemia and underscores the importance of a comprehensive workup, including medication review, laboratory tests, radiography, and biopsy, with consideration for excisional biopsy.

## Linked entities

- **Chemicals:** calcitonin (PubChem CID 118984394), zoledronic acid (PubChem CID 68740), 1,25-dihydroxyvitamin D (PubChem CID 5280453), 25-hydroxyvitamin D (PubChem CID 5353325), TSH (PubChem CID 1150)
- **Diseases:** sarcoidosis (MONDO:0008399), hypercalcemia (MONDO:0001566), type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, PTHLH (parathyroid hormone like hormone) [NCBI Gene 5744] {aka BDE2, HHM, PLP, PTHR, PTHRP}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** hypercalcemia (MESH:D006934), polydipsia (MESH:D059606), bone destruction (MESH:D001847), toxicity (MESH:D064420), vitamin A (MESH:D014802), Sarcoidosis (MESH:D012507), hypertension (MESH:D006973), thyrotoxicosis (MESH:C566386), noncaseating granulomas (MESH:D006099), type 2 diabetes (MESH:D003924), lymphoma (MESH:D008223), polyuria (MESH:D011141), osseous lesions (MESH:D000070896), multiple myeloma (MESH:D009101), lung lesions (MESH:D008171), adrenal insufficiency (MESH:D000309), malignancies (MESH:D009369), granulomatous (MESH:D013968), retroperitoneal lymphadenopathy (MESH:D012186), granulomatous inflammation (MESH:D007249), pulmonary involvement (MESH:C566343), hyperthyroidism (MESH:D006980), lymphadenopathy (MESH:D008206), granulomatous disease (MESH:D006105)
- **Chemicals:** 25-hydroxy vitamin D (MESH:C104450), hematoxylin (MESH:D006416), 25(OH)D (-), 1,25(OH)2D (MESH:C097949), calcium (MESH:D002118), calcitriol (MESH:D002117), prednisone (MESH:D011241), Steroid (MESH:D013256), cortisol (MESH:D006854), cinacalcet (MESH:D000069449), mycophenolate (MESH:D009173), vitamin D (MESH:D014807), thiazide (MESH:D049971), lithium (MESH:D008094), zoledronic acid (MESH:D000077211), vitamin A (MESH:D014801)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932943/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932943/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932943/full.md

---
Source: https://tomesphere.com/paper/PMC12932943